Hancock Jaffe Laboratories Inc Beta
What is the Beta of Hancock Jaffe Laboratories Inc?
The Beta of Hancock Jaffe Laboratories Inc is 0.00
What is the definition of Beta?
BETA indicates whether a stock is more or less volatile than the market as a whole. A beta less than 1 indicates that the stock is less volatile than the market, while a beta more than 1 indicates that the stock is more volatile. Volatility is measured as the fluctuation of the price around the mean.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta of companies in the Health Care sector on NASDAQ compared to Hancock Jaffe Laboratories Inc
What does Hancock Jaffe Laboratories Inc do?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Companies with beta similar to Hancock Jaffe Laboratories Inc
- Vision Marine Technologies has Beta of 0.00
- Ely Gold Royalties has Beta of 0.00
- Glacier Lake Resources has Beta of 0.00
- Magnum Mining and Exploration has Beta of 0.00
- Africa Opportunity Fund has Beta of 0.00
- Fulcrum Utility Services has Beta of 0.00
- Hancock Jaffe Laboratories Inc has Beta of 0.00
- Gullewa has Beta of 0.00
- S.A.L. Steel has Beta of 0.00
- Andina Acquisition III has Beta of 0.00
- Andina Acquisition III has Beta of 0.00
- Brilliant Acquisition has Beta of 0.00
- Indokem has Beta of 0.00